Principia Biopharma
South San Francisco
About Principia Biopharma
Principia Biopharma is a private, pre-clinical stage company initially focused on the discovery and development of differentiated small molecule drugs targeting inflammatory/autoimmune diseases as well as cancer. The company expects to submit an IND for its lead program in 2013 and continues to invest in additional programs and its reversible covalent platform.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Estimated revenue: $50K – $100K
- Total funding: $337.8M
- Funding stage: M&A
- Last round: Post-IPO Equity (Oct 2019)
- Ticker: nasdaq:PRNB
- Website: principiabio.com
- Phone: (650) 416-7700
Industries & Categories
Biopharma, Biotechnology, Life Science, Oncology
Social Profiles
Canonical: https://fsome.com/organization/principia-biopharma-43862 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.